Institut Mérieux is Mérieux NutriSciences’ mother company (majority shareholder with 70% of shares) and acts as a holding company.
Institut Mérieux is committing its experience in industrial biology to serve medicine and public health across the globe.
Institut Mérieux has a comprehensive approach from prevention to therapy through diagnosis. Its main three companies -bioMérieux, Transgène, Mérieux NutriSciences - have made major advances in the fight against infectious diseases and cancers, as well as in the field of nutrition and food safety. Created in 1897, Institut Mérieux employs more than 17,000 people worldwide, has an international presence in 150 countries and a direct presence in more than 40 countries.